References
- WHO. Influenza at the human-animal interface. http://www.who.int/influenza/human_animal_interface/h7n9/en/ (Accessed on 13 June 2018).
- ZhangQH7N9 influenza viruses are transmissible in ferrets by respiratory dropletScience2013341 410 41410.1126/science.1240532
- BelserJAPathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and miceNature201350155655910.1038/nature12391
- RichardMLimited airborne transmission of H7N9 influenza A virus between ferretsNature201350156056310.1038/nature124763819191
- WatanabeTCharacterization of H7N9 influenza A viruses isolated from humansNature201350155155510.1038/nature123923891892
- ZhouJBiological features of novel avian influenza A (H7N9) virusNature201349950050310.1038/nature12379
- GaoYIdentification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian hostPLoS Pathog.20095e100070910.1371/journal.ppat.10007092791199
- LiXGenetics, receptor binding property, and transmissibility in mammals of naturally isolated H9N2 avian influenza virusesPLoS Pathog.201410e100450810.1371/journal.ppat.10045084239090
- Qi, W. et al. Emergence and adaptation of a novel highly pathogenic H7N9 influenza virus in birds and humans from a 2013 human-infecting low-pathogenic ancestor. J. Virol.92, e00921–17 (2018).
- ShiJH7N9 virulent mutants detected in chickens in China pose an increased threat to humansCell Res.2017271409142110.1038/cr.2017.1295717404
- ZhouLPreliminary epidemiology of human infections with highly pathogenic avian influenza A(H7N9) virus, China, 2017Emerg. Infect. Dis.2017231355135910.3201/eid2308.1706405547798
- Yang, L. et al. genesis and spread of newly emerged highly pathogenic H7N9 avian viruses in mainland China. J. Virol.91, e01277–17 (2017).
- BartSAA cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adultsSci. Transl. Med20146234ra25510.1126/scitranslmed.3008761
- ChenZDevelopment of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferretsJ. Virol.2014887016702310.1128/JVI.00100-144054345
- BahlKPreclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza virusesMol. Ther.2017251316132710.1016/j.ymthe.2017.03.0355475249
- WongSSA single dose of whole inactivated H7N9 influenza vaccine confers protection from severe disease but not infection in ferretsVaccine2014324571457710.1016/j.vaccine.2014.06.0164106487
- ChenHGeneration and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidateVaccine2003214430443610.1016/S0264-410X(03)00430-4
- SmithGEDevelopment of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virusVaccine2013314305431310.1016/j.vaccine.2013.07.043
- JosephTA live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferretsVirology200837812313210.1016/j.virol.2008.05.0212586151
- LeungHCAn H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virusEmerg. Microbes Infect.2015410.1038/emi.2015.224417706
- KongHA live attenuated vaccine prevents replication and transmission of H7N9 virus in mammalsSci. Rep.2015510.1038/srep112334462025
- ZhangFHuman infections with recently-emerging highly pathogenic H7N9 avian influenza virus in ChinaJ. Infect.201775717510.1016/j.jinf.2017.04.001
- Quan, C. et al. New threats from H7N9 influenza virus: spread and evolution of high- and low-pathogenicity variants with high genomic diversity in wave five. J. Virol.92, e00301–18 (2018).
- Shi, J. et al. Rapid evolution of H7N9 highly pathogenic viruses that emerged in China in 2017. Cell Host & Microbe 24, 1-11 (2018).
- XiongXReceptor binding by an H7N9 influenza virus from humansNature201349949649910.1038/nature12372
- ZhangHThe PB2 E627K mutation contributes to the high polymerase activity and enhanced replication of H7N9 influenza virusJ. General. Virol.20149577978610.1099/vir.0.061721-0
- WangGH6 influenza viruses pose a potential threat to human healthJ. Virol.2014883953396410.1128/JVI.03292-133993743
- Wang, Z. et al. A single-amino-acid substitution at position 225 in hemagglutinin alters the transmissibility of Eurasian avian-like H1N1 swine influenza virus in guinea pigs. J. Virol.91, e00800–17 (2017).
- HerfstSAirborne transmission of influenza A/H5N1 virus between ferretsScience20123361534154110.1126/science.12133624810786
- LowenACMubarekaSTumpeyTMGarcia-SastreAPalesePThe guinea pig as a transmission model for human influenza virusesProc. Natl Acad. Sci. USA20061039988999210.1073/pnas.0604157103
- YangHPrevalence, genetics, and transmissibility in ferrets of Eurasian avian-like H1N1 swine influenza virusesProc. Natl Acad. Sci. USA201611339239710.1073/pnas.1522643113
- ZhangYH5N1 hybrid viruses bearing 2009/H1N1 virus genes transmit in guinea pigs by respiratory dropletScience20133401459146310.1126/science.1229455
- ZhangYKey molecular factors in hemagglutinin and PB2 contribute to efficient transmission of the 2009 H1N1 pandemic influenza virusJ. Virol.2012869666967410.1128/JVI.00958-123446561
- MoA. H7N9 recombinant vaccine will be used in chickens in China. http://www.moa.gov.cn/gk/yjgl_1/yjcl/ (Accessed on 19 June 2017).
- OIE. The H7N9 highly pathogenic viruses outbreak in Chickens in Shaanxi, Ningxia, Liaoning and Shanxi Province, China. http://www.oie.int/en/animal-health-in-the-world/update-on-avian-influenza/2018/ (Accessed on 13 June 2018).
- MaassabHFBryantMLThe development of live attenuated cold-adapted influenza virus vaccine for humansRev. Med Virol.1999923724410.1002/(SICI)1099-1654(199910/12)9:4<237::AID-RMV252>3.0.CO;2-G
- CoxRJBrokstadKAOgraPInfluenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.Scand. J. Immunol.20045911510.1111/j.0300-9475.2004.01382.x
- FanSImmunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primatesPLoS Pathog.20095e100040910.1371/journal.ppat.10004092669169
- ShiJProtective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in miceAntivir. Res20129334635310.1016/j.antiviral.2012.01.001
- LeeYJEnhancement of the safety of live influenza vaccine by attenuating mutations from cold-adapted hemagglutininVirology20164911910.1016/j.virol.2016.01.022